Matthew Parker Ph.D.

Matt is a Shareholder in the Intellectual Property & Technology and Corporate practice groups at Maynard Cooper. He advises clients on a wide range of complex transactions involving intellectual property and technology, including technology licensing, strategic collaborations, mergers and acquisitions, joint ventures, supply and distribution arrangements, and other strategic commercial agreements. Matt’s practice focuses on advising both established and emerging companies in a variety of technology-intensive sectors, including biotechnology, pharmaceuticals, software, SaaS, healthcare, consumer electronics, gaming, social media, e-commerce, and other online business models.

As a complement to his transactional IP practice, Matt also assists his clients with day-to-day commercial and corporate matters as well as the preparation and prosecution of patent applications, particularly in the life sciences. Matt also provides guidance on integrating advice from other legal experts, such as litigators and regulatory advisors, so that it aligns with companies’ corporate strategy and practices.

Matt earned his Ph.D. in Biomedical Sciences with a concentration in immunology. He also completed research in the fields of immunology, translational medicine, molecular biology and analytical chemistry, which serves as the backbone to his understanding of the variety of complex scientific and technical matters required when working on behalf of his clients to protect their intellectual property.

Affiliations

• Alabama Bar Association (Intellectual Property, Entertainment, & Sports Law Section)
• BioAlabama
• Fly Quest